Pricing Log in Create free account

Cumberland Pharmaceuticals Inc. (CPIX) vs Citius Oncology, Inc. (CTOR)

Cumberland Pharmaceuticals Inc. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $113.0M against $69.4M — 1.6× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −26.2%) and the lower return on invested capital (−67.2% vs −34.2%). Across the 13 metrics below, Cumberland Pharmaceuticals Inc. leads on 10 and Citius Oncology, Inc. on 3.

Valuation

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.58 n/m 2.11
P/B 6.29 2.00 1.78
Price to free cash flow 186.79 n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 2.73 n/m 2.73
Earnings yield (9.89%) (62.67%) (4.38%)
Free cash flow yield 0.54% (39.72%) 0.00%

Profitability

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Gross margin 82.80% — 53.94%
Operating margin (17.39%) 0.00% 0.00%
Net margin (26.17%) 0.00% 0.00%
Free cash flow margin 1.38% 0.00% 0.00%
Return on equity (48.76%) (126.58%) (0.40%)
Return on assets (16.70%) (45.20%) (3.32%)
Return on invested capital (34.23%) (67.15%) 0.00%

Growth

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% — 10.01%
EPS growth (last fiscal year) 58.70% (9.68%) 49.06%
Revenue growth, 5-year CAGR 3.52% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.50 0.05
Current ratio 0.96 0.73 2.31
Net debt to EBITDA (4.58) (0.40) 0.97

Dividend

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.57%
Payout ratio — — 0.27

Size

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Market cap 112.97m 69.36m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack